The announcement of a significant private placement financing deal typically signals investor confidence and potential for growth, leading to a positive short-term impact on the company's stock price. Given the size of the deal relative to Plus Therapeutics, this influx of capital is likely to be viewed positively by the market, hence the increase in stock price.